• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Infect Dis. Ascertainment rate of novel coronavirus disease (COVID-19) in Japan

tetano

Editor, Senior Moderator
Int J Infect Dis. 2020 May 7. pii: S1201-9712(20)30292-7. doi: 10.1016/j.ijid.2020.04.080. [Epub ahead of print]
Ascertainment rate of novel coronavirus disease (COVID-19) in Japan.


Omori R[SUP]1[/SUP], Mizumoto K[SUP]2[/SUP], Nishiura H[SUP]3[/SUP].

Author information




Abstract

OBJECTIVE:

To estimate the ascertainment rate of novel coronavirus (COVID-19).
METHODS:

We analyzed the epidemiological dataset of confirmed cases with COVID-19 in Japan as of 28 February 2020. A statistical model was constructed to describe the heterogeneity of reporting rate by age and severity. We estimated the number of severe and non-severe cases, accounting for under-ascertainment.
RESULTS:

The ascertainment rate of non-severe cases was estimated at 0.44 (95% confidence interval: 0.37, 0.50), indicating that unbiased number of non-cases would be more than twice the reported count.
CONCLUSIONS:

Severe cases are twice more likely diagnosed and reported than other cases. Considering that reported cases are usually dominated by non-severe cases, the adjusted total number of cases is also about a double of observed count. Our finding is critical in interpreting the reported data, and it is advised to interpret mild case data of COVID-19 as always under-ascertained.
Copyright ? 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.



KEYWORDS:

coronavirus; diagnosis; epidemiology; outbreak; reporting; statistical model; viruses


PMID:32389846DOI:10.1016/j.ijid.2020.04.080
Free full text
 
Back
Top Bottom